We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Axcella Health (AXLA - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Axcella Health is one of 887 individual stocks in the Medical sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. AXLA is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for AXLA's full-year earnings has moved 35.51% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, AXLA has gained about 34.41% so far this year. Meanwhile, the Medical sector has returned an average of 0.17% on a year-to-date basis. This shows that Axcella Health is outperforming its peers so far this year.
Breaking things down more, AXLA is a member of the Medical - Biomedical and Genetics industry, which includes 381 individual companies and currently sits at #50 in the Zacks Industry Rank. On average, stocks in this group have gained 13.57% this year, meaning that AXLA is performing better in terms of year-to-date returns.
AXLA will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
In-Depth Zacks Research for the Tickers Above
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Axcella Health (AXLA - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Axcella Health is one of 887 individual stocks in the Medical sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. AXLA is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for AXLA's full-year earnings has moved 35.51% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, AXLA has gained about 34.41% so far this year. Meanwhile, the Medical sector has returned an average of 0.17% on a year-to-date basis. This shows that Axcella Health is outperforming its peers so far this year.
Breaking things down more, AXLA is a member of the Medical - Biomedical and Genetics industry, which includes 381 individual companies and currently sits at #50 in the Zacks Industry Rank. On average, stocks in this group have gained 13.57% this year, meaning that AXLA is performing better in terms of year-to-date returns.
AXLA will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.